Author:
Rosen Jeffrey,Sancheti Parag,Fierlinger Anke,Niazi Faizan,Johal Herman,Bedi Asheesh
Funder
Ferring Pharmaceutics Inc.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference28 articles.
1. Bitton R. The economic burden of osteoarthritis. Am J Manag Care. 2009;15(8 Suppl):S230–5.
2. Losina E, Daigle ME, Reichmann WM, et al. Disease-modifying drugs for knee osteoarthritis: can they be cost-effective? Osteoarthr Cartil. 2014;21(5):655–67.
3. American Academy of Orthopaedic Surgeons. Treatment of osteoarthritis of the knee: evidence based guideline 2nd Edition. AAOS. 2013.
4. Losina E, Walensky RP, Holt HL, et al. Ten million quality-adjusted life years lost due to knee osteoarthritis (OA) in the US elderly population: the role of obesity. The American College of Rheumatology Annual Scientific Meeting. 2008. https://acr.confex.com/acr/2008/webprogram/Paper2046.html .
5. Bhala N, Emberson J, Merhi A, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013;382(9894):769–79.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献